KLK3 and benign prostatic hyperplasia: As shown in Table 1, the PRS score was associated with an increased risk of BPH, with the risk being significantly higher in Q4 compared to Q1 (OR = 1.51, 95% CI = 1.274–1.783, p < 0.0001), after adjusting for prostate-specific antigen (PSA) level.